ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
10,37
14-ноября-24 10:43:36
15 мин. задержка
Акции
-0,10
-0,96%
Сегодняшний диапазон
10,29 - 10,59
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Arcutis Announces Pricing of $100 Million Public Offering
19 окт 2023 23:45:47 Источник Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 окт 2023 16:04:44 Источник Nasdaq GlobeNewswire
-
13 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
06 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 окт 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
25 сен 2023 09:00:47 Источник Nasdaq GlobeNewswire
-
19 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 сен 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
12 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
07 сен 2023 08:15:50 Источник Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
05 сен 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Publishes Annual Environmental, Social, and Governance (ESG) Report
31 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
29 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Appoints Interim Chief Financial Officer (CFO)
18 авг 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
10 авг 2023 08:16:31 Источник Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update
08 авг 2023 16:02:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 авг 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
17 июл 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 июл 2023 16:00:00 Источник Nasdaq GlobeNewswire